Could COX-2 Inhibition With Celecoxib Have Role in Breast Cancer?ByR. Charles Coombes, MD, PhDJanuary 8th 2018This video highlights results of REACT, a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.